Together, our data suggest a novel positive feedback loop between YB1 expression and chemoresistance, therefore creating a vicious oncogenic environment which activates a sustained tumor growth and metastasis, which is more active in AA TNBC tumors, and ultimately contributes to the disparities in health outcomes in AA women with TNBC disease. This evidence concerns the gene YBX1 and neoplasm.